Swiss Study: Colorectal Cancer Rising in Under-50s
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- University of Geneva researchers analyzed 96,410 colorectal cancer cases in Switzerland from 1980 to 2021, finding that incidence in adults under 50 rose by roughly 0.5% per year, reaching nearly 7 cases per 100,000 person-years.
- Older adults aged 50–74 saw the opposite trend — incidence dropped 1.7% in men and 2.8% in women, a decline the researchers attribute to screening programs.
- Younger patients were far more likely to be diagnosed late — nearly 28% of under-50 patients had metastatic disease at diagnosis, compared with about 20% of older patients.
- The increase was not uniform — rectal cancers rose in both men and women, while right-sided colon cancers increased specifically in young women, pointing to distinct biological or environmental mechanisms.
- Dr. Jeremy Meyer and Dr. Evelyne Fournier led the study using data from the Geneva Cancer Registry and Switzerland's National Agency for Cancer Registration, published in the European Journal of Cancer.
- Colorectal cancer globally caused nearly 900,000 deaths in 2022, with Switzerland recording about 4,500 new diagnoses annually and ranking among the country's three most common cancers.
- The U.S. has lowered the screening age to 45, and Meyer says screening should start even earlier for those with elevated familial or hereditary risk.
Why it matters: The 0.5% annual rise in early-onset cases, sustained for 40 years, means public-health messages framing colorectal cancer as a '50-plus' disease are now out of step with the epidemiology. For under-50 patients, the 28% metastatic rate at diagnosis exposes a symptom-recognition gap that screening thresholds alone won't close.
